Insulin-like growth factor-I action on glucose transport in acute renal failure

American Journal of Physiology

Volumn 271, Issue 2 PART 2, 1996, Pages

  Mak, Robert H K ^a   Mehls, Otto ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acidosis; Insulin resistance

Indexed keywords

SOMATOMEDIN C;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GLUCOSE TRANSPORT; INSULIN METABOLISM; INSULIN RESISTANCE; MALE; METABOLIC ACIDOSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD GLUCOSE; GLUCOSE CLAMP TECHNIQUE; INSULIN; INSULIN-LIKE GROWTH FACTOR I; KIDNEY FAILURE, ACUTE; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS;

EID: 0029736802     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajprenal.1996.271.2.f440     Document Type: Article

References (25)

1. Briggs, J. D., K. D. Buchanan, R. G. Luke, and M. T. McKiddie. Role of insulin in glucose intolerance in uremia. Lancet 1:462-464,1967.
2. Caro, J. F., J. Poullus, O. Ittoop, W. J. Pories, E. G. Flickenger, and M. K. Sinha. Insulin-like growth factor-I binding in hepatocytes from human liver, human hepatoma and normal regenerating fetal rat liver. J. Clin. Invest. 81: 976-981, 1988.
3. Cianciaruso, B., V. Bellizzi, R. Napoli, L. Sacca, and J. D. Kopple. Hepatic uptake and release of glucose, lactate, and amino acids in acutely uremie dogs. Metabolism, 40: 261-269, 1994.
4. Clark, A. S., and W. E. Mitch. Muscle protein turnover and glucose uptake in acute renal failure. J. Clin. Invest. 72: 836-845,1983.
5. DeFronzo, R. A., A. Alvestrand, D. Smith, R. Hendler, E. Hendler, and J. Wahren. Insulin resistance in uremia. J. Clin. Invest. 67: 563-570,1981.
6. DeFronzo, R. A., and A. D. Beckles. Glucose intolerance following chronic metabolic acidosis in man. Am. J. Physiol. 236 (Endocrinol. Metab. Gastrointest. Physiol. 5): B328-E334, 1979.
7. DeFronzo, R. A., J. Tobin, and R. Andres. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 237 (Endocrinol. Metab. Gastrointest. Physiol. 6): E214-E223,1979.
8. Froesch, E. R., and J. Zapf. Insulin-like growth factors and insulin, comparative aspects. Diabetologia 28: 485-493,1985.
9. Feinstein, E. L, M. J. Blumenkrantz, M. Healy, A. Hoffler, H. Silberman, S. G. Massry, and J. D. Kopple. Clinical and metabolic responses to parenteral nutrition in acute renal failure. Medicine 60:124-137,1981.
10. Fouque, D., S. C. Peng, and J. D. Kopple. Impaired metabolic response to recombinant insulin-like growth factor-I in dialysis patients. Kidney Int. 47: 876-883,1995.
11. Frolich, J., J. Schohnerich, G. Hoppe-Seyler, K. P. Maier, H. Talke, P. Schollmeyer, and W. Gerok. The effect of acute uremia on gluconeogenesis in isolated perfused rat livers. Eur. J. Clin. Invest. 4:453-458,1974.
12. Furlanetto, R. W., L. E. Underwood, J. J. Van Wyk, and A. J. D'Ercole. Estimation of Sm-C levels in normals and patients with pituitary disease by KIA. J. Clin. Invest. 60:648-656,1977.
13. Guler, H. P., J. Zapf, and E. R Froesch. Short-term metabolic effects of recombinant human insulin-like growth factor-I in healthy adults. N. Engl. J. Med. 317:137-140,1987.
14. Jacob, R, E. Barrett, G. Plewe, K. D. Fagan, and R. S. Sherwin. Acute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat. Comparison with insulin. J. Clin. Invest. 83:1717-1723,1989.
15. Jacob, R. J., R. S. Sherwin, L. Bowen, D. Fryburg, K. D. Fagin, W. V. Tamborlane, and G. I. Shulman. Metabolic effects of IGP-I and insulin in spontaneously diabetic BB/w rats. Am.J. Physiol. 260 (Endocrinol. Metab.,23): E262-E268,1991.
16. Kokot, F., and J. Kuska. Influence of extracorporal dialysis on glucose utilization and insulin secretion in patients with acute renal failure. Ear. J. Clin. Invest. 3:105-111,1973.
17. Kuzuya, H., N. Matsura, M. Sakamoto, H. Makino, Y. Sakamoto, T. Kadowski, Y. Suzuki, M. Kobayashi, Y. Akazawa, and M. Nomura. Trial of insulinlike growth factor I therapy for patients with extreme insulin resistance syndromes. Diabetes 42:696-705,1993.
18. Leahy, J. L., and K. M. Vandekerkhove. Insulin-like growth factor I at physiological concentrations is a potent inhibitor of insulin secretion. Endocrinology 126:1593-1598,1990.
19. Mondon, E., C. B. Dolkas, and G. M. Heaven. The site of insulin resistance in acute uremia. Diabetes 27:571-576,1978.
20. Moxley III, R. T., P. Arner, A. Moss, A. Skottner, M. Fox, D. James, and J. N. Livingston. Acute effects of insulin-like growth factor I and insulin on glucose metabolism in vivo. Am. J. Physiol. 259 (Endocrinol. Metab. 22): E561-E567,1990.
21. Powell, D. R., R. G. Rosenfeld, B. K. Baker, F. Liu, and R. Hintz. Serum somatomedin levels in adults with chronic renal failure: the importance of measuring insulin-like growth factor I (IGF-I) and IGF-II in acid-chromatographed urémie serum. J. Clin. Endocrinol. Metab. 63:1186-1192,1986.
22. Rossetti, L., D. Smith, G. I. Shulman, D. Papachristou, and R. A. Defronzo. Correction of hyperglycemia with phorizin normalizes tissue sensitivity to insulin in diabetic rats. J. Clin. Invest. 79:1510-1515,1987.
23. Smith, D., L. Rossetti, E. Ferrannini, C. M. Johnson, C. Cobelli, G. Toffolo, L. D. Katz, and R. Defronzo. In vivo glucose metabolism in the awake rat: tracer and insulin clamp studies. Metabolism 36:1167-1174,1987.
24. Schoenle, E. J., P. D. Zenobi, T. Torresani, E. A. Werder, M. Zachman, and E. R. Froesch. Recombinant human insulin-like growth factor I reduces hyperglycemia in patients with extreme insulin resistance. Diabetologia 34:675-679,1991.
25. Zapf, J., E. Schoenle, and E. R. Froesch. Insulin-like growth factors I and II: some biological actions and receptor binding characteristics of two purified constituents of non suppressible insulin-like activity of human serum. Eur. J. Biochem. 87: 285-296,1978.